E
Cytosorbents Corporation CTSO
$1.13 $0.032.73%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings CTSO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Weak
Risk Grade D-
Reward Grade E
Rating Factors CTSO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Fair
Efficiency Index Very Weak
Solvency Index Good
Total Return Index Weak
Volatility Index Weak
Beta / Standard Deviation CTSO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 0.97
Price History CTSO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 11.88%
30-Day Total Return 13.00%
60-Day Total Return 39.49%
90-Day Total Return 29.81%
Year to Date Total Return 22.83%
1-Year Total Return 16.97%
2-Year Total Return -64.91%
3-Year Total Return -66.07%
5-Year Total Return -72.84%
52-Week High % Change -29.81%
52-Week Low % Change 61.43%
Price CTSO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $1.61
52-Week Low Price $0.70
52-Week Low Price (Date) Jul 01, 2024
52-Week High Price (Date) Feb 14, 2025
Valuation CTSO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 61.79M
Enterprise Value 82.91M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.36
Earnings Per Share Growth -32.05%
Price/Earnings To Growth --
Price/Sales (TTM) 1.63
Price/Book (Q) 4.74
Enterprise Value/Revenue (TTM) 2.20
Price $1.13
Enterprise Value/EBITDA (TTM) -4.19
Enterprise Value/EBIT -3.88
Market Cap Category Micro Cap
Dividends and Shares CTSO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 54.45M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info CTSO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 732 329 8885
Address 305 College Road East Princeton, NJ 08540
Website www.cytosorbents.com
Country United States
Year Founded 1997
Profitability CTSO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -56.63%
Profit Margin -49.47%
Management Effectiveness CTSO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -28.01%
Return on Equity --
Income Statement CTSO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 37.74M
Total Revenue (TTM) 37.74M
Revenue Per Share $0.69
Gross Profit (TTM) 23.67M
EBITDA (TTM) -19.80M
EBIT (TTM) -21.37M
Net Income (TTM) -18.67M
Net Income Avl. to Common (TTM) -18.67M
Total Revenue Growth (Q YOY) 6.58%
Earnings Growth (Q YOY) 74.61%
EPS Diluted (TTM) -0.36
EPS Diluted Growth (Q YOY) 79.30%
Balance Sheet CTSO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 5.69M
Cash Per Share (Q) $0.10
Total Current Assets (Q) 16.60M
Total Preferred Equity (Q) --
Total Equity (Q) 13.00M
Current Ratio (Q) 1.969
Book Value Per Share (Q) $0.24
Total Assets (Q) 47.80M
Total Current Liabilities (Q) 8.43M
Total Debt (Q) 26.81M
Total Liabilities (Q) 34.80M
Total Common Equity (Q) 13.00M
Cash Flow CTSO - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) -681.20K
Cash from Financing (TTM) 21.37M
Net Change in Cash (TTM) 2.12M
Levered Free Cash Flow (TTM) -11.70M
Cash from Operations (TTM) -18.49M
Weiss Ratings